Identification of multiple allosteric sites on the M1 muscarinic acetylcholine receptor

被引:14
作者
Espinoza-Fonseca, LM [1 ]
Trujillo-Ferrara, JG
机构
[1] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA
[2] Inst Politecn Nacl, Escuela Super Med, Secc Estudios Posgrado & Invest, Mexico City 11340, DF, Mexico
[3] Inst Politecn Nacl, Escuela Super Med, Dept Bioquim, Mexico City 11340, DF, Mexico
关键词
M-1 muscarinic acetylcholine receptor; G-protein coupling receptors; staurosporine; allosteric sites; docking simulations; molecular dynamics; Alzheimer's disease;
D O I
10.1016/j.febslet.2005.10.069
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Staurosporine and four staurosporine derivatives were docked on the rhodopsin-based homology model of the M, muscarinic acetylcholine receptor in order to localize the possible allosteric sites of this receptor. It was found that there were three major allosteric sites, two of which are located at the extracellular face of the receptor, and one in the intracellular domain of the receptor. In the present study, the localization of these binding sites is described for the first time. The present study confirms the existence of multiple allosteric sites on the M, muscarinic receptor, and lays the ground for further experimental and computational analysis to better understand how muscarinic receptors are modulated via their allosteric sites. These findings will also help to design and develop novel drugs acting as allosteric modulators of the M, receptor, which can be used in the treatment of the Alzheimer's disease. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:6726 / 6732
页数:7
相关论文
共 25 条
[1]
Multiple allosteric sites on muscarinic receptors [J].
Birdsall, NJM ;
Lazareno, S ;
Popham, A ;
Saldanha, J .
LIFE SCIENCES, 2001, 68 (22-23) :2517-2524
[2]
Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets? [J].
Bissantz, C ;
Bernard, P ;
Hibert, M ;
Rognan, D .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2003, 50 (01) :5-25
[3]
MUSCARINIC RECEPTORS AND NOVEL STRATEGIES FOR THE TREATMENT OF AGE-RELATED BRAIN DISORDERS [J].
EHLERT, FJ ;
ROESKE, WR ;
YAMAMURA, HI .
LIFE SCIENCES, 1994, 55 (25-26) :2135-2145
[4]
Ellis J., 2002, UNDERSTANDING G PROT, P349
[5]
Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists [J].
Fisher, A .
JAPANESE JOURNAL OF PHARMACOLOGY, 2000, 84 (02) :101-112
[6]
M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease -: Implications in future therapy [J].
Fisher, A ;
Pittel, Z ;
Haring, R ;
Bar-Ner, N ;
Kliger-Spatz, M ;
Natan, N ;
Egozi, I ;
Sonego, H ;
Marcovitch, I ;
Brandeis, R .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2003, 20 (03) :349-356
[7]
ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY - A RAPID ACCESS TO ATOMIC CHARGES [J].
GASTEIGER, J ;
MARSILI, M .
TETRAHEDRON, 1980, 36 (22) :3219-3228
[8]
Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors [J].
Gnagey, AL ;
Seidenberg, M ;
Ellis, J .
MOLECULAR PHARMACOLOGY, 1999, 56 (06) :1245-1253
[9]
Structure and activation of muscarinic acetylcholine receptors [J].
Hulme, EC ;
Lu, ZL ;
Saldanha, JW ;
Bee, MS .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 :29-34
[10]
NAMD2:: Greater scalability for parallel molecular dynamics [J].
Kalé, L ;
Skeel, R ;
Bhandarkar, M ;
Brunner, R ;
Gursoy, A ;
Krawetz, N ;
Phillips, J ;
Shinozaki, A ;
Varadarajan, K ;
Schulten, K .
JOURNAL OF COMPUTATIONAL PHYSICS, 1999, 151 (01) :283-312